Immunovant, HQ

www.immunovant.com
1000 Park Forty Plaza, Suite 210
Durham, NC 27713

Company Info

Year Established
2018

Ticker
IMVT

Exchange
NASDAQ

Contacts

Eric Venker, M.D., Pharm. D
CEO

Company Description

Immunovant is a clinical-stage biopharmaceutical company focused on enabling normal lives for people with autoimmune diseases.